说明与适用边界
此页按所列地区、版本归档。标签内容可能更新,具体产品请核对原始来源;本站关联表示阅读线索,不表示药品与器械可兼容或可替换。
spl product data elements
GLADSKIN ECZEMACT ECZEMA COLLOIDAL OATMEAL OATMEAL OATMEAL WATER GLYCERIN PETROLATUM CETOSTEARYL ALCOHOL MINERAL OIL ARGININE HYDROCHLORIDE SODIUM CHLORIDE POLYOXYL 20 CETOSTEARYL ETHER TROMETHAMINE CALCIUM CHLORIDE
spl unclassified section
Drug Facts
Company Information Distributed by Micreos North America, Inc. Encinitas, CA 92024 gladskin.com
活性成分 / Active ingredient
Active Ingredient Colloidal Oatmeal (0.02%)
用途 / Purpose
Purpose Skin Protectant
适应证 / Indications and usage
Uses Temporarily protects and helps relieve minor skin irritation and itching due to eczema.
警告 / Warnings
Warnings For external use only. When using this product do not get into eyes. Stop use and ask a doctor if: Conditions worsen Symptoms last more than 7 days or clear up and occur again within a few days. Keep out of reach of children . If swallowed, get medical help or contact a poison control center right away.
使用中 / When using
When using this product do not get into eyes.
停用事项 / Stop use
Stop use and ask a doctor if: Conditions worsen Symptoms last more than 7 days or clear up and occur again within a few days.
儿童安全 / Keep out of reach of children
Keep out of reach of children . If swallowed, get medical help or contact a poison control center right away.
用法用量原文 / Dosage and administration
Directions Apply as needed
辅料 / Inactive ingredients
Inactive Ingredients Water, Glycerin, Petrolatum, Mineral Oil, Cetearyl Alcohol, Ceteareth-20, Arginine HCl, Sodium Chloride, Tromethamine, Calcium Chloride, sr-(Methionyl Staphylococcus Simulans Polypeptide-1 Dipeptide-53 Staphylococcus Phage 2638A Polypeptide-1)* *Micreobalance™ is a proprietary smart protein that rebalances the skin microbiome.
questions
Questions? (888) 802-1668
package label principal display panel
Product Packaging 1
来源、版本与许可
- 资料类型
- 美国药品标签原文
- 版本
- 2 / 20260225
- 获取时间
- 2026-10-08
- 许可
- openFDA public data; retain original label attribution. See 查看来源 and dataset source notices. Public access does not imply approval or unrestricted rights to every submitted label.

